Results 61 to 70 of about 5,507 (191)

The effectiveness of parenteral agents to mitigate relapses after severe acute migraine headache presentations: A systematic review and network analysis

Headache: The Journal of Head and Face Pain, Volume 64, Issue 10, Page 1181-1199, November/December 2024.
Abstract Objectives To compare the effectiveness of parenteral agents to reduce relapse in patients with acute migraine and identify factors that predict relapse. Background Following discharge from emergency settings, many patients with acute migraine will experience a relapse in pain; severe relapses may result in re‐visits to emergency settings ...
Scott Kirkland, Jillian Meyer, Lloyd Visser, Sandra Campbell, Cristina Villa‐Roel, Benjamin W. Friedman, Nana Owusu Essel, Brian H. Rowe   +7 more
wiley   +1 more source

Cluster Headache and Its Cousins: A Family of Pain Management Problems

Pain Research and Management, 2000
Cluster headache causes great misery because of the severity, frequency and repetitiveness of its attacks, and the fear (justified in a few sufferers) that the attacks will respond to nothing and will never cease.
John Edmeads
doaj   +1 more source

Application of Factorial and Doehlert Designs for the Optimization of the Simultaneous Separation and Determination of Antimigraine Drugs in Pharmaceutical Formulations by RP-HPLC-UV

International Journal of Analytical Chemistry, 2019
A sensitive, precise, accurate, and specific isocratic reversed-phase high-performance liquid chromatographic (RP-HPLC) method for the simultaneous separation and determination of zolmitriptan, naratriptan, dihydroergotamine, ketotifen, and pizotifen in ...
Sami Jebali, Chaouki Belgacem, Mohamed Radhouen Louhaichi, Senda Bahri, Latifa Latrous El Atarche   +4 more
doaj   +1 more source

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations

Journal of Pain Research, 2020
Rafia Shafqat, Yadira Flores-Montanez, Victoria Delbono, Stephanie J Nahas Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USACorrespondence: Stephanie J Nahas 900 Walnut St., Suite 200, Philadelphia, PA 19107-5509, USATel +1 215 ...
Shafqat R, Flores-Montanez Y, Delbono V, Nahas SJ   +3 more
doaj  

Enhancing Intranasal Delivery and Bioavailability of Dihydroergotamine Utilizing Chitosan Nanoparticles [PDF]

, 2023
Ahmed Alastal, Amani D. Abu Kwaik, Azzam A. Malkawi, Sarah Baltzley, Abeer M. Al-Ghananeem   +4 more
openalex   +1 more source

Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamine

Drug Design, Development and Therapy, 2013
Robert J Noveck,1 Pamela S Douglas,2 Shein-Chung Chow,3 Barry Mangum,4 Shashidhar Kori,5 Donald J Kellerman51Duke Clinical Research Unit, Division of Clinical Pharmacology, Duke University School of Medicine, Durham, NC, USA; 2Imaging Program, Duke ...
Noveck RJ, Douglas PS, Chow SC, Mangum B, Kori S, Kellerman DJ   +5 more
doaj  

Bleeding after hip arthroplasty not increased by heparin plus dihydroergotamine [PDF]

, 1987
S. Winter Christensen, Torben Jørgensen, A Bjerg-Nielsen, Per Hölmich, Benn Duus   +4 more
openalex   +1 more source

In-Patient Treatment of Chronic Daily Headache Using Dihydroergotamine: a Long-term Follow-up Study [PDF]

, 1998
Tamara Pringsheim, David Howse
openalex   +1 more source

In silico Screening of Food and Drug Administration-approved Compounds against Trehalose 2-sulfotransferase (Rv0295c) in Mycobacterium tuberculosis: Insights from Molecular Docking and Dynamics Simulations

International Journal of Mycobacteriology
Background: Tuberculosis (TB) remains a prominent global health challenge, distinguished by substantial occurrences of infection and death. The upsurge of drug-resistant TB strains underscores the urgency to identify novel therapeutic targets and ...
Devesh Sharma, Sakshi Gautam, Nalini Srivastava, Deepa Bisht   +3 more
doaj   +1 more source

Journal Club: Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome [PDF]

, 2016
Yohannes W. Woldeamanuel, Méabh O’Hare, Danielle D. DeSouza, Robert P. Cowan   +3 more
openalex   +1 more source